Clinical Study


Warning: Invalid argument supplied for foreach() in /home/uchealth/public_html/wp-content/plugins/uchealth-physicians/UCPhysicians.php on line 1321

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Assignment Study To Assess The Efficacy And Safety Of Reparixin In Pancreatic Islet Auto-Transplantation.

Posted Date: Aug 12, 2017

  • Investigator: Syed Ahmad
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to evaluate the safety and effectiveness of the study drug in patients who have undergone pancreatic islet auto-transplantation.

Criteria:

To Be Eligible Patients Must Have Been Diagnosed With Chronic Pancreatitis And Are Scheduled To Have Pancreas Removed And Have A Pancreatic Islet Auto-Transplant

Keywords:

Pancreatic Islet Auto-Transplantation, Chronic, Rep0112, Pancreatitis

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.